Hot on the tail of AstraZeneca’s Imfinzi, Bristol Myers Squibb’s PD-1/L1 inhibitor Opdivo has expanded its non-small cell lung cancer (NSCLC) net with an ...
The checkpoint inhibitor is now approved, based on CheckMate 77T findings, for neoadjuvant/adjuvant use in patients with resectable NSCLC.
The FDA on Thursday expanded the U.S.-approved indications for Bristol-Myers Squibb's (NYSE:BMY) blockbuster immunotherapy ...
Proteins are constantly wrapping and unwrapping DNA, and even minor missteps can lead to cancer. A new study reveals a previously unknown part of this dance -- one with significant implications for ...
Walmart’s employees and their dependents are being offered expanded cancer treatment with doctors at the Mayo Clinic through ...
Walmart’s employees and their dependents are being offered expanded cancer treatment with doctors at the Mayo Clinic through the retailer’s insurance coverage.
Walmart's employees and their dependents are being offered expanded cancer treatment with doctors at the Mayo Clinic through ...
1d
The retail giant’s move comes as more employers seek better care options and are paying particular attention to cancer ...
Walmart is expanding its insurance coverage to offer advanced cancer treatment for employees and their dependents at the Mayo ...
Walmart’s employees and their dependents are being offered expanded cancer treatment with doctors at the Mayo Clinic through ...
Researchers from Barcelona’s Germans Trias i Pujol Institute and Josep Carreras Leukaemia Research Institute have found a ...
About three months from opening, the the new Nebraska Medicine cancer facility in Kearney now has a name: Nebraska Medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback